47.72
price up icon1.88%   0.88
after-market After Hours: 47.72
loading
Q 32 Bio Inc stock is traded at $47.72, with a volume of 87,209. It is up +1.88% in the last 24 hours and up +6.64% over the past month. Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$46.84
Open:
$46.28
24h Volume:
87,209
Relative Volume:
0.83
Market Cap:
$575.49M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.06%
1M Performance:
+6.64%
6M Performance:
+86.48%
1Y Performance:
+0.00%
1-Day Range:
Value
$46.07
$48.48
1-Week Range:
Value
$45.00
$49.68
52-Week Range:
Value
$13.59
$53.79

Q 32 Bio Inc Stock (QTTB) Company Profile

Name
Name
Q 32 Bio Inc
Name
Phone
781-999-0232
Name
Address
830 WINTER STREET, WALTHAM
Name
Employee
41
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
QTTB's Discussions on Twitter

Q 32 Bio Inc Stock (QTTB) Latest News

pulisher
06:59 AM

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - Kilgore News Herald

06:59 AM
pulisher
Nov 03, 2024

Brokerages Set Q32 Bio Inc. (NASDAQ:QTTB) Target Price at $72.33 - Defense World

Nov 03, 2024
pulisher
Oct 28, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.6%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight - India Shorts

Oct 28, 2024
pulisher
Oct 27, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5% – Here’s Why - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Raymond James Initiates Coverage of Q32 Bio (QTTB) with Strong Buy Recommendation - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Q32 Bio (NASDAQ:QTTB) Research Coverage Started at Raymond James - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Upstream Bio stock rallies 32% following upsized $255M IPO - MSN

Oct 24, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clinical Outlook - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clin - GuruFocus.com

Oct 16, 2024
pulisher
Oct 16, 2024

ADX-097, potential AAV therapy, fares well in healthy volunteers - ANCA Vasculitis News

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 14, 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - cnhinews.com

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys 685,151 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Decreases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Citizens Community Bancorp, Inc. (NASDAQ:CZWI) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Grows Stock Holdings in OptimumBank Holdings, Inc. (NASDAQ:OPHC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Acquires Shares of 66,500 Waldencast plc (NASDAQ:WALD) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Takes $265,000 Position in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys Shares of 84,300 Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

private equity firms who own 52% along with institutions invested in Q32 Bio Inc. (NASDAQ:QTTB) saw increase in their holdings value last week - Simply Wall St

Oct 10, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Shares Up 4.8% – What’s Next? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 4.8%What's Next? - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

Analysts Set Q32 Bio Inc. (NASDAQ:QTTB) PT at $68.80 - MarketBeat

Oct 06, 2024
pulisher
Oct 01, 2024

Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes - TipRanks

Oct 01, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 29, 2024

Sherwin-Williams (SHW) Set to Announce Quarterly Earnings on Monday - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Ensign Peak Advisors Inc Purchases 38,750 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Bank of New York Mellon Corp Makes New $315,000 Investment in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 26, 2024
pulisher
Sep 23, 2024

Bruce K. Posey Sells 1,330 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

QXO (NASDAQ:QXO) Trading Up 4.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Trading Down 3.7% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex

Sep 23, 2024
pulisher
Sep 22, 2024

Q32 Bio Inc.(NasdaqGM: QTTB) added to S&P Global BMI Index - Marketscreener.com

Sep 22, 2024
pulisher
Sep 22, 2024

Mutual of America Capital Management LLC Trims Stock Position in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Client First Investment Management LLC Purchases New Stake in ProShares Ultra QQQ (NYSEARCA:QLD) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Davidson Capital Management Inc. Boosts Holdings in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Acquires 2,595 Shares of Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Q32 Bio (NASDAQ:QTTB) Sees Strong Trading Volume - MarketBeat

Sep 19, 2024
pulisher
Sep 17, 2024

Q32 Bio (NASDAQ:QTTB) Trading 8.2% Higher - MarketBeat

Sep 17, 2024
pulisher
Sep 16, 2024

Harvard Management Co. Inc. Purchases New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 16, 2024
pulisher
Sep 14, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Receives $68.80 Average PT from Analysts - Defense World

Sep 14, 2024
pulisher
Sep 14, 2024

EchoStar (NASDAQ:SATS) Hits New 12-Month High Following Analyst Upgrade - Defense World

Sep 14, 2024
pulisher
Sep 12, 2024

Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $52.64 - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

Wells Fargo & Company Begins Coverage on Q32 Bio (NASDAQ:QTTB) - MarketBeat

Sep 12, 2024

Q 32 Bio Inc Stock (QTTB) Financials Data

There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Q 32 Bio Inc Stock (QTTB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Violette Shelia M.
Chief Scientific Officer
Oct 11 '24
Option Exercise
3.12
4,574
14,271
17,874
Violette Shelia M.
Chief Scientific Officer
Oct 08 '24
Option Exercise
3.12
13,300
41,496
13,300
TZIANABOS ARTHUR
Director
Mar 25 '24
Sale
24.20
265
6,413
7,983
Alloway Paul
See Remarks
Mar 25 '24
Sale
24.21
268
6,488
2,596
Michaud Charles Jr
See Remarks
Mar 25 '24
Sale
24.20
75
1,815
927
TZIANABOS ARTHUR
Director
Jan 09 '24
Sale
0.57
13,037
7,445
128,778
Alloway Paul
See Remarks
Jan 03 '24
Sale
0.57
7,280
4,120
28,036
Michaud Charles Jr
See Remarks
Jan 03 '24
Sale
0.57
1,708
975
11,598
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):